SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Texas Biotech (TXB)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
834 13 0 TXB
Emcee:  Andrew R. Sicotte Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
809The second generation anti-ET-A. J Med Chem 2001 Apr 12;44(8):1211-6 Related Arkeokalani'nui-6/19/2001
808SKB has an ET-A receptor antagonist that it has experimented with in a stroke mokeokalani'nui-6/11/2001
807ABT's ET-1 inhibitor, bone mestastases. 331 Endothelin A Receptor Blockadkeokalani'nui-5/23/2001
806<i>[I would like to understand the relationship among Endothelin-A antagonkeokalani'nui-5/14/2001
805Abbott Endo-A results in prostate cancer metastasized to the bone. [I would likeokalani'nui-5/14/2001
804Abbott 627, showing A blockade better than non-spec. J Hepatol 2000 Nov;33(5):7keokalani'nui-5/14/2001
803From Message 15795290 . I'll post the abstract later. Thanks Peter. >&keokalani'nui-5/14/2001
802Press Release SOURCE: Texas Biotechnology Corporation Preclinical Results With Akeokalani'nui-5/9/2001
801From 1Q01 CC: Company believes its ETi's are the most potent and selective keokalani'nui-5/3/2001
800The Argatroban stroke trial (180 pts, 30 sites, P2, topline expected 2H02) are pkeokalani'nui-5/3/2001
799TXB only talks about Generation 1, which was OK efficacy but had some side effeckeokalani'nui-4/20/2001
798That's Bosentan. which is about eight zillion years old. So..... where dscaram(o)uche-4/20/2001
797From FT. Taking DNA down 4+ on this news was unnecessary, though with the asthmkeokalani'nui-4/20/2001
796Friday April 20, 1:01 am Eastern Time Press Release Phase III Clinical Trial oscaram(o)uche-4/20/2001
795Recent insider transactions are.....purchases. biz.yahoo.com I hanging around keokalani'nui-3/27/2001
794Quite a substantial 13g filing by Oracle partners. sec.gov Following Franklin&keokalani'nui-3/24/2001
793Four things occur to me, based on my imperfect information. First, apparently opalapril-9/25/2000
792I was looking at some biotech laggards with interesting prospects. In my inestimLarry Liebman-9/24/2000
791Sorry. I was rushed. But what's one or another letter of the alphabet betweeopalapril-9/12/2000
790Opala, not the WSJ but the WST. Small but important difference.aknahow-9/12/2000
789<i>"WST does punish those who don't respond. You can vote them &qopalapril-9/12/2000
788Mr. Prill WST does punish those who don't respond. You can vote them "aknahow-9/12/2000
787Don't agree. The companies are well aware that the WST is an important respaknahow-9/11/2000
786<i>"Baxter's answer was astute. "Ask XOMA"</i> opalapril-9/11/2000
785Opala, seriously, the WST qa page works if a company wants to answer. Someone saknahow-9/10/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News